NEUROTHERAPEUTICS PHARMA, INC.

Profile

Company Names

NEUROTHERAPEUTICS PHARMA, INC.

Addresses

8750 W. BRYN MAWR AVENUE, SUITE 440, CHICAGO, IL 60631

8420 W. BRYN MAWR AVENUE, SUITE 860, CHICAGO, IL 60631

8420 W. BYRN MAWR AVENUE, SUITE 860, CHICAGO, IL 60631

Phone Numbers

(773) 444-4180

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2006

State Incorporated:

DE

Total Amount Raised:

$33,711,530.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2011-12-15 
$12,000,000.00 
$47,487,500.00 
$35,487,500.00 
Equity 
2
2010-05-20 
$18,511,530.00 
$43,527,750.00 
$25,016,220.00 
Equity 
1
2008-12-22 
$3,200,000.00 
$5,750,000.00 
$2,550,000.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
THOMAS 
R. 
BECK, M.D. 
DIRECTOR
NEUROTHERAPEUTICS PHARMA, INC.
KAREN 
 
BOEZI 
DIRECTOR
NEUROTHERAPEUTICS PHARMA, INC.   |  REDWOOD BIOSCIENCE INC   |  ACRIGEN BIOSCIENCES, INC.
JASON 
 
BROWN, PH.D. 
DIRECTOR
NEUROTHERAPEUTICS PHARMA, INC.
HOLLI 
A. 
CARLSON 
EXECUTIVE OFFICER
NEUROTHERAPEUTICS PHARMA, INC.
STEPHEN 
D. 
COLLINS, M.D., PH.D. 
EXECUTIVE OFFICER, DIRECTOR
NEUROTHERAPEUTICS PHARMA, INC.
RAJEEV 
 
DADOO, PH.D. 
DIRECTOR
NEUROTHERAPEUTICS PHARMA, INC.
LUKE 
 
EVNIN, PH.D. 
DIRECTOR
NEUROTHERAPEUTICS PHARMA, INC.   |  SYNDAX PHARMACEUTICALS INC
COREY 
 
GOODMAN, PH.D. 
DIRECTOR
NEUROTHERAPEUTICS PHARMA, INC.
ELAINE 
V. 
JONES, PH.D. 
DIRECTOR
NEUROTHERAPEUTICS PHARMA, INC.
HEATH 
 
LUKATCH, PH.D. 
DIRECTOR
NEUROTHERAPEUTICS PHARMA, INC.   |  RED TREE VENTURE FUND SPV I, LLC   |  VIRSTI THERAPEUTICS, INC.   |  RED TREE VENTURE FUND, L.P.   |  RED TREE SPV MI, L.P.   |  RED TREE VENTURE FUND II, L.P.
PHILLIP 
F. 
MORGAN, PH.D. 
DIRECTOR
NEUROTHERAPEUTICS PHARMA, INC.
CHRISTINE 
 
SIU 
DIRECTOR
NEUROTHERAPEUTICS PHARMA, INC.   |  EIDOS THERAPEUTICS, INC.   |  MONTE ROSA THERAPEUTICS, INC.   |  BRIGHT PEAK THERAPEUTICS, INC.
MICHAEL 
 
VENUTI, PH.D 
EXECUTIVE OFFICER
NEUROTHERAPEUTICS PHARMA, INC.
TODD 
 
VERDOORN, PH.D. 
EXECUTIVE OFFICER
NEUROTHERAPEUTICS PHARMA, INC.
STEPHEN 
P. 
WANASKI 
EXECUTIVE OFFICER
NEUROTHERAPEUTICS PHARMA, INC.
STEPHEN 
P. 
WANASKI, PH.D. 
EXECUTIVE OFFICER
NEUROTHERAPEUTICS PHARMA, INC.
BRIAN 
B. 
WILLIAMS 
EXECUTIVE OFFICER
NEUROTHERAPEUTICS PHARMA, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2011-12-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-12-15 
2010-05-28
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-05-20 
2009-01-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2008-12-22 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#